SPIEGELMAN DANIEL K

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
39
Insider Sells Sum
$51.74M

Insider Activity of SPIEGELMAN DANIEL K

According to the SEC Form 4 filings, SPIEGELMAN DANIEL K, being in a position of

  1. director at Myriad Genetics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 7576 shares for $167,013,
    over all time since 2021-05-28, has bought 0 shares, and sold 32919 shares for $792,264.

The largest sale of all time was on 2015-05-18 and amounted to 72274 shares of BioMarin Pharmaceutical Inc. for $9.37M.

Biography of SPIEGELMAN DANIEL K

No biography is available at this moment.

2024-06-04SaleMyriad Genetics, Inc.
MYGN
director
3,788
0.0041%
$22.05$83,525+9.09%
2024-06-03SaleMyriad Genetics, Inc.
MYGN
director
3,788
0.0041%
$22.04$83,488+8.69%
2023-06-02SaleMyriad Genetics, Inc.
MYGN
director
8,638
0.0104%
$23.01$198,760-13.7%
2022-06-06SaleMyriad Genetics, Inc.
MYGN
6,424
0.0082%
$19.25$123,673+7.21%
2021-06-17SaleMyriad Genetics, Inc.
MYGN
director
3,139
0.004%
$30.52$95,795-12.26%
2021-05-28SaleMyriad Genetics, Inc.
MYGN
director
7,142
0.0094%
$28.99$207,023-3.89%
2019-04-01SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
26,946
0.015%
$89.00$2.4M-7.96%
2019-03-27SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
200
0.0001%
$90.00$18,000-6.4%
2018-06-22SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
20,000
0.0113%
$99.00$1.98M-5.19%
2018-04-23SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
22,118
0.0125%
$82.15$1.82M+14.77%
2017-03-16SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
3,978
0.0023%
$91.96$365,817-2.01%
2017-03-06SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
4,606
0.0027%
$93.32$429,832-2.56%
2017-03-01SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
10,000
0.0058%
$94.50$945,000-4.47%
2017-02-28SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
60,000
0.0291%
$78.55$4.71M-4.57%
2017-01-09SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
10,000
0.0057%
$90.00$900,000-1.58%
2016-11-09SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
40,000
0.0229%
$90.61$3.62M-2.8%
2016-08-01SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
8,000
0.0047%
$99.33$794,640-10.23%
2016-06-06SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
3,298
0.002%
$89.14$293,984-0.18%
2016-05-31SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
41,682
0.0198%
$69.23$2.89M-0.39%
2016-05-23SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Financial Officer
7,538
0.0047%
$87.07$656,368+4.5%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.